Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed Feb 25, 2016 · 10-K · 56 days after period end · 0001564590-16-013358
| Metric | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|
| Net Income | -$64.68M | -$44.42M | -$8.82M | -$62.07M |
| EPS Diluted | -$1.44 | -$1.08 | -$0.23 | -$2.36 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Feb 25, 2016 · 56 d after period end
